「clinical」の検索結果

Use when a task needs the judgment of a dermatologist — triaging a pigmented lesion for melanoma risk, choosing a biopsy technique and reading the pathology in clinical context, staging a skin cancer to decide margins or Mohs referral, escalating psoriasis/eczema treatment by severity score, or managing isotretinoin risk under REMS/iPLEDGE rules.

日本語の概要は準備中です。原文の説明を表示しています。

Use when a task needs the judgment of a Community Health Worker — screening a client for social-determinants-of-health barriers, triaging a referral to housing/food/transportation resources, translating a clinical instruction into a teach-back-verified action plan, or deciding whether a no-show pattern signals disengagement or an unaddressed barrier.

日本語の概要は準備中です。原文の説明を表示しています。

Use when a task needs the judgment of a Cardiovascular Technologist — measuring and grading a cardiac or vascular ultrasound finding, tracking contrast/anticoagulation/radiation limits during a live cath lab procedure, choosing between imaging modalities for a clinical question, or writing up a diagnostic study for physician sign-off.

日本語の概要は準備中です。原文の説明を表示しています。

Use when a task needs the judgment of a bioinformatics technician — running or QC-gating a next-generation sequencing pipeline, triaging a failed or borderline sequencing run, deciding whether a variant call set is clinically/research reportable, or writing a sample-level QC report.

日本語の概要は準備中です。原文の説明を表示しています。

Use when a task needs the judgment of a Biologist — designing a study and identifying its true experimental unit before data collection starts, running a power analysis to size a sample, judging whether a published or preclinical finding warrants trust without independent replication, sequencing IACUC/IBC/field-permit approvals before biosafety or wildlife work begins, or scoping a grant-funded research plan against realistic funding odds.

日本語の概要は準備中です。原文の説明を表示しています。

Use when a task needs the judgment of a biomedical/bioengineering engineer — running a design control phase (inputs, outputs, verification, validation) for a medical device, scoring a Design FMEA and deciding whether a failure mode needs mitigation, planning a human factors/usability validation study, building a design traceability matrix, or writing a design verification or risk-mitigation report. Distinct from a regulatory-affairs-specialist (owns the submission/clearance process, not the engineering itself) and from a clinical-data-manager/biostatistician (trial data and analysis, not device design).

日本語の概要は準備中です。原文の説明を表示しています。

Use when a task needs the judgment of a Biostatistician — designing a clinical trial's sample size and analysis plan, choosing a survival-analysis or censoring-aware method, preparing a DSMB safety readout, or judging whether a trial's efficacy claim survives ITT vs. per-protocol scrutiny.

日本語の概要は準備中です。原文の説明を表示しています。

Screening for drug-drug interactions — mechanistic prediction, database checks, and clinical risk assessment.

日本語の概要は準備中です。原文の説明を表示しています。

Copy-number variant analysis — detection from sequencing/arrays, segmentation, and clinical interpretation.

日本語の概要は準備中です。原文の説明を表示しています。

Comprehensive healthcare system compliance and security audit: review HIPAA Privacy and Security Rule adherence, check HITECH and 21st Century Cures Act obligations, validate clinical data integrity for HL7 FHIR and patient safety.

日本語の概要は準備中です。原文の説明を表示しています。

Analyze behavioral health outcome tracking systems for clinical measurement validity, treatment effectiveness, and provider performance comparison.

日本語の概要は準備中です。原文の説明を表示しています。

Audit rehabilitation setback prediction systems for clinical risk modeling and early intervention. Triggers: you need to evaluate risk factor models (Charlson, Elixhauser), early warning indicators for functional decline.

日本語の概要は準備中です。原文の説明を表示しています。

Use this skill when configuring or troubleshooting FSC Referral Management: setting up referral types via ReferralRecordTypeMapping custom metadata, routing referrals through Lead Assignment Rules keyed on the Expressed Interest picklist, tracking Referrer Score, and partner referral visibility in Experience Cloud. Trigger keywords: referral routing, FSC referral types, ReferralRecordTypeMapping, Expressed Interest picklist, partner referral Contact, Referrer Score Experience Cloud. NOT for clinical referrals in Health Cloud — use admin/referral-management-health. NOT for standard Lead capture and conversion outside FSC — use admin/lead-management-and-conversion.

日本語の概要は準備中です。原文の説明を表示しています。

Configure care plan templates, problems, goals, and tasks in Salesforce Health Cloud - the Integrated Care Management (ICM) model (Spring '23+, FHIR R4-aligned) and the legacy CarePlanTemplate__c + Case Tasks model. Trigger keywords: care plan template, ICM care plan, PGI library, action plan template, problem definition, goal definition. NOT for enrolling a patient into a clinical program - use admin/care-program-management. NOT for care team workflow, transition of care and SDOH barriers - use admin/care-coordination-requirements.

日本語の概要は準備中です。原文の説明を表示しています。

ผู้ช่วยสัตวแพทย์ — species-specific reference (สุนัข/แมว/exotic) + DDx + drug dosing weight-based + clinical pearl สำหรับสัตวแพทย์ที่มีใบประกอบวิชาชีพเท่านั้น

日本語の概要は準備中です。原文の説明を表示しています。

Self-help mental wellness coach — daily journaling prompts + gratitude practice + emotional regulation tools + thought reframing สำหรับคนทั่วไป (ไม่ใช่ clinical therapy)

日本語の概要は準備中です。原文の説明を表示しています。

ผู้ช่วยทันตแพทย์ — dental code reference + treatment planning + materia medica dental + clinical pearl สำหรับทันตแพทย์ที่มีใบประกอบวิชาชีพเท่านั้น

日本語の概要は準備中です。原文の説明を表示しています。

ผู้ช่วยสรุปงานวิจัย + differential diagnosis list + drug interaction check + clinical pearl สำหรับบุคลากรการแพทย์เท่านั้น

日本語の概要は準備中です。原文の説明を表示しています。

Drafts healthcare chart audit protocols covering clinical documentation review, coding accuracy, and billing compliance. Aligns with Medicare CoPs, OIG Compliance Program Guidance, RAC preparedness, federal sentencing guidelines, and the 60-day overpayment rule. Use when drafting routine periodic audits, targeted risk reviews, proactive compliance measures, or post-regulatory-update assessments.

日本語の概要は準備中です。原文の説明を表示しています。

Drafts an Adverse Event Reporting Policy compliant with 21 CFR 312.32 (IND safety reporting), 21 CFR 314.80 (postmarketing), and ICH E2A, with multi-jurisdictional overlays (EMA, PMDA, Health Canada). Covers seriousness/causality frameworks, expedited reporting timelines, roles, documentation standards, training mandates, and QA mechanisms. Use when drafting or updating an adverse event reporting policy, pharmacovigilance policy, AE/SAE reporting SOP, or safety reporting framework for a pharmaceutical company, CRO, biotech, or clinical research institution.

日本語の概要は準備中です。原文の説明を表示しています。

Produces a plain-language comparison of advance directives and POLST/MOLST forms, covering legal status, clinician signatures, emergency precedence, clinical appropriateness, and document coordination. Use when the user asks about advance directive vs. POLST, living will vs. DNR, which document EMS follows, POLST vs. MOLST vs. POST, whether a healthy person needs a POLST, or document coordination in elder law, estate planning, or serious illness contexts.

日本語の概要は準備中です。原文の説明を表示しています。

Expert in Jungian analytical psychology, depth psychology, shadow work, archetypal analysis, dream interpretation, active imagination, addiction/recovery through Jungian lens, and the individuation process - grounded in primary sources and clinical frameworks. Activate on 'Jung', 'Jungian', 'shadow work', 'archetypes', 'dream interpretation', 'active imagination', 'individuation', 'anima', 'animus', 'collective unconscious', 'addiction', 'recovery', 'spiritus contra spiritum'. NOT for therapy or diagnosis (only licensed analysts diagnose), active psychosis, severe dissociation, or replacing the relational container of actual Jungian analysis.

日本語の概要は準備中です。原文の説明を表示しています。

Build weighted gene co-expression networks to identify modules of co-regulated genes, relate them to phenotypes, and find hub genes using WGCNA, hdWGCNA, MEGENA, CEMiTool, and Gaussian graphical models. Covers signed-network choice, soft-threshold selection, module preservation, and the marginal-vs-partial-correlation distinction. Use when finding co-expression modules, identifying hub genes, relating gene networks to clinical or experimental traits, or building single-cell co-expression networks. For directed TF-target inference see scenic-regulons and grn-inference; for condition rewiring see differential-networks.

日本語の概要は準備中です。原文の説明を表示しています。

Controls error rates across thousands of simultaneous tests in genomics discovery using false-discovery-rate methods (Benjamini-Hochberg 1995; Benjamini-Yekutieli 2001 for arbitrary dependence; Storey q-value with pi0 estimation; local FDR; independent filtering Bourgon 2010; covariate-weighted FDR via IHW Ignatiadis 2016), plus family-wise error control (Bonferroni, Holm) and the GWAS genome-wide threshold. Covers the FDR-versus-FWER choice as the discovery-versus-confirmatory distinction, the dependence assumptions behind BH (PRDS) versus BY, pi0 estimation, the independent-filtering and false-coverage-rate traps, and reproducibility ranking via IDR (Li 2011). Use when correcting p-values from genome-wide tests, choosing between BH/BY/q-value/Bonferroni, setting an FDR threshold, applying IHW or independent filtering, or interpreting q-values. For confirmatory trials with few pre-specified endpoints (closed testing, graphical/gatekeeping), see clinical-biostatistics/multiplicity-graphical.

日本語の概要は準備中です。原文の説明を表示しています。